Goldman Sachs Resumes Comerica (CMA) at Sell
Get Alerts CMA Hot Sheet
Price: $88.67 --0%
Rating Summary:
6 Buy, 28 Hold, 7 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
6 Buy, 28 Hold, 7 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
Goldman Sachs resumes coverage on Comerica (NYSE: CMA) with a Sell rating and $28 price target.
The firm sees risk to the company's asset sensitivity-driven premium valuation as out-year rate hikes and margin expansion expectations are right-sized. In addition, limited ability to further lower deposit costs would result in NIM compression in the near term, the firm said. Loan growth also has more problems from attrition at the company's above-average concentration in C&I and third-highest market share disproportionately expose it to competition. Lastly, they see little leverage to improving environmental costs, something others in the sector will see an earnings benefit from.
For an analyst ratings summary and ratings history on Comerica click here. For more ratings news on Comerica click here.
Shares of Comerica closed at $30.39 yesterday.
The firm sees risk to the company's asset sensitivity-driven premium valuation as out-year rate hikes and margin expansion expectations are right-sized. In addition, limited ability to further lower deposit costs would result in NIM compression in the near term, the firm said. Loan growth also has more problems from attrition at the company's above-average concentration in C&I and third-highest market share disproportionately expose it to competition. Lastly, they see little leverage to improving environmental costs, something others in the sector will see an earnings benefit from.
For an analyst ratings summary and ratings history on Comerica click here. For more ratings news on Comerica click here.
Shares of Comerica closed at $30.39 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
- Vireo Growth completes acquisition of C21 Investments
- BMO starts chip stocks coverage: Here are its preferred picks
Create E-mail Alert Related Categories
Hot New Coverage, New CoverageRelated Entities
Goldman Sachs, EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share